semaglutide after pregnancy drives weight loss through cAMP-dependent mechanisms in GLP1R-expressing hindbrain neurons New Science Suggests Semaglutide Improves

Applicable Procedure Codes: 61850, 61860, 61863, 61864, 61867, 61868, 61885, 61886, 61889, 61891, 61886, 64999, L8679, L8680, L8682, L8685, L8686, L8687, L8688

Quality varies by pharmacy, so verifying state licensure and, where possible, third-party testing matters

Oscillatory Devices for Respiratory Disorders Policy number: VII.35 Summary: High-frequency chest wall oscillation and oscillatory PEP devices are covered for cystic fibrosis, primary ciliary dyskinesia, and bronchiectasis

Patients taking GLP-1 medications with insulin or sulfonylureas have an increased risk of hypoglycemia and should discuss timing of all medications with their healthcare provider to minimize this risk